Clinical Trial Update: Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating interferon alfa-2b after chemotherapy and peripheral stem cell transplantation in patients with recurrent or refractory Hodgkin's lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Lymphoma Study Association | Conditions: Lymphoma | Phase 3 | Status: UNKNOWN